Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

All results

2 results for tests

  • ITN095AI DESIGNATE

    This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis.…

    Ages
    8 Years - 45 Years
    Sexes
    All
  • Protocol TN-25

    The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr…

    Ages
    8 Years - 45 Years
    Sexes
    All